1. Home
  2. FOSL vs ATYR Comparison

FOSL vs ATYR Comparison

Compare FOSL & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOSL
  • ATYR
  • Stock Information
  • Founded
  • FOSL 1984
  • ATYR 2005
  • Country
  • FOSL United States
  • ATYR United States
  • Employees
  • FOSL N/A
  • ATYR N/A
  • Industry
  • FOSL Consumer Specialties
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FOSL Consumer Discretionary
  • ATYR Health Care
  • Exchange
  • FOSL Nasdaq
  • ATYR Nasdaq
  • Market Cap
  • FOSL 128.0M
  • ATYR 105.8M
  • IPO Year
  • FOSL 1993
  • ATYR 2015
  • Fundamental
  • Price
  • FOSL $2.10
  • ATYR $0.97
  • Analyst Decision
  • FOSL Strong Buy
  • ATYR Buy
  • Analyst Count
  • FOSL 1
  • ATYR 6
  • Target Price
  • FOSL $5.00
  • ATYR $8.88
  • AVG Volume (30 Days)
  • FOSL 1.5M
  • ATYR 7.8M
  • Earning Date
  • FOSL 11-05-2025
  • ATYR 11-11-2025
  • Dividend Yield
  • FOSL N/A
  • ATYR N/A
  • EPS Growth
  • FOSL N/A
  • ATYR N/A
  • EPS
  • FOSL N/A
  • ATYR N/A
  • Revenue
  • FOSL $1,083,797,000.00
  • ATYR N/A
  • Revenue This Year
  • FOSL N/A
  • ATYR $420.85
  • Revenue Next Year
  • FOSL N/A
  • ATYR $1,513.40
  • P/E Ratio
  • FOSL N/A
  • ATYR N/A
  • Revenue Growth
  • FOSL N/A
  • ATYR N/A
  • 52 Week Low
  • FOSL $0.86
  • ATYR $0.68
  • 52 Week High
  • FOSL $4.40
  • ATYR $7.29
  • Technical
  • Relative Strength Index (RSI)
  • FOSL 39.57
  • ATYR 32.08
  • Support Level
  • FOSL $2.29
  • ATYR $0.94
  • Resistance Level
  • FOSL $2.43
  • ATYR $1.02
  • Average True Range (ATR)
  • FOSL 0.31
  • ATYR 0.08
  • MACD
  • FOSL -0.05
  • ATYR 0.12
  • Stochastic Oscillator
  • FOSL 0.86
  • ATYR 31.27

About FOSL Fossil Group Inc.

Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: